Rubylynn Basilio
Family · Belleville, NJNPI 1487387593
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,275 of the $3,999 with a category attached, or 81.9%. It is spread thinly across 35 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,467, 2.4 times the $617 reported in 2022. Among family clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 162 payments — averaging $24.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$670
- Daiichi Sankyo Inc.$592
- E.r. Squibb & Sons, L.L.C.$408
- Incyte Corporation$407
- AbbVie$233
- GSK$151
- plus $2K from 29 others
What the payments were for
- Food & beverage$3,27582%
- Education$72418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 38 | $670 |
| Daiichi Sankyo Inc. | 25 | $592 |
| E.r. Squibb & Sons, L.L.C. | 5 | $408 |
| Incyte Corporation | 14 | $407 |
| AbbVie | 7 | $233 |
| GSK | 3 | $151 |
| Astellas Pharma US Inc | 2 | $149 |
| Seagen Inc. | 2 | $112 |
| Karyopharm Therapeutics Inc. | 7 | $111 |
| Johnson & Johnson | 6 | $99 |
| Pfizer | 2 | $90 |
| Novartis | 5 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $87 |
| Bayer | 4 | $86 |
| Tempus AI, Inc | 1 | $83 |
| Lilly USA, LLC | 4 | $73 |
| Amgen | 5 | $68 |
| Merck | 4 | $61 |
| Regeneron Healthcare Solutions, Inc. | 3 | $54 |
| Adaptive Biotechnologies Corporation | 2 | $46 |
| Beone Medicines USA, Inc. | 2 | $42 |
| G1 Therapeutics, Inc. | 2 | $29 |
| Acrotech Biopharma Inc. | 1 | $29 |
| Geron Corporation | 2 | $29 |
| Sanofi | 1 | $23 |
| Genentech USA, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Pharmaessentia USA Corporation | 1 | $18 |
| Legend Biotech USA Inc. | 1 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $18 |
| Beigene USA, Inc. | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $17 |
| Sobi, Inc | 1 | $17 |
| Coherus Oncology, Inc. | 1 | $17 |
| Syndax Pharmaceuticals, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,999 in reported general payments places this provider in the 90th percentile of 2,692 family providers in New Jersey.
Other family in Belleville
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
- Kimberly ClementeEatontown$25K
- Toni Michelle SeibertColumbus$23K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.